Can PSMA-PET be a better way to select patients for an intermittent treatment? Results from a prospective cohort. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...

An urologist explains why a PSA test is just the first step in the screening process for prostate cancer screenings. Learn what contributes to your PSA results.

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by age 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Add Yahoo as a preferred source to see more of our stories on Google. PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly ...

KPG-121, a novel cereblon modulator, in patients with metastatic castration resistant prostate cancer: Results of a phase I multiple ascending dose study. Baseline PSMA PET/CT as a predictive ...

Checking PSA levels following treatment is crucial among patients with nonmetastatic, unfavorable risk prostate cancer, according to the co-author of a recent study. Prostate-specific antigen (PSA) ...

This marks the second year for the “A PSA on PSA” campaign, which ClevelandDx started in 2023 to educate patients and their families and caregivers about the importance of screening for prostate ...

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that the treatment is working. A recent real-world study indicates that ...

HT Health Talk: Prostate cancer is common but often silent. Should you get checked earlier if your father or brother had it?

A multicenter French study using full-length 16S rDNA sequencing found that men with prostate cancer harbor a more diverse ...